课题基金 / 基金详情

项目摘要

项目成果

STEPHEN F VATNER的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
 DESCRIPTION (provided by applicant): Mammalian hibernation is a unique and potent strategy for survival in winter when food and water are not available. Our hypothesis is that some of the mechanisms utilized for protection against the stress in winter, might also be used to protect ischemic myocardium, even though hibernating mammals do not have coronary artery disease or myocardial ischemia. The focus of this proposal is to examine the woodchucks' protection in winter against complete coronary artery occlusion and its consequences of remodeling and the development of heart failure. After a complete occlusion of a coronary artery the major mechanism that can ameliorate the effects of ischemia relate to the coronary vessels and development of angiogenesis, which is supported by the preliminary data in this application. Our preliminary data also indicate that vascular stiffness and the composition of vessels are altered in winter thereby permitting enhanced blood flow. Potential cellular mechanisms include cAMP response element-binding protein (CREB) and nitric oxide synthase (NOS). It is important to keep in mind that these studies will be conducted for the first time in a natural model of cardioprotection, quite different from traditional studies in experimental animal models or genetically altered mice. Our Hypothesis: Woodchucks prepare for winter by developing mechanisms that extensively modify their blood vessels resulting in reduced vascular stiffness and induction of new coronary vessels, which provide blood flow to the ischemic heart and attenuate heart failure development and remodeling after chronic, complete coronary artery occlusion.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
A Novel Pharmacological Inhibitor of Adenylyl Cyclase Type 5 to Treat Alzheimer's Disease
  • 批准号:
    10608477
  • 项目类别:
  • 资助金额:
    $25.21万
  • 财政年份:
    2022
  • 负责人:
    STEPHEN F VATNER
  • 依托单位:
Skeletal Muscle and Brown Adipose Mechanisms Mediating Cardiovascular Risk Factor Protection in RGS14 KO
  • 批准号:
    9900047
  • 项目类别:
  • 资助金额:
    $53.43万
  • 财政年份:
    2017
  • 负责人:
    STEPHEN F VATNER
  • 依托单位:
Angiogenesis Protection Induced by sFRP3 Myocyte/Vascular Cross-Talk
  • 批准号:
    9900045
  • 项目类别:
  • 资助金额:
    $56.45万
  • 财政年份:
    2017
  • 负责人:
    STEPHEN F VATNER
  • 依托单位:
RGS 14 Disruption, Vascular Effects Leading to Cardioprotection
  • 批准号:
    8888575
  • 项目类别:
  • 资助金额:
    $62.94万
  • 财政年份:
    2015
  • 负责人:
    STEPHEN F VATNER
  • 依托单位:
海外基金